Authors
Latest:
Impact of Medicaid Preferred Drug List on Long-Acting Opioid UsersAn opioid preferred drug list was not associated with an increase in emergency department visits or hospitalizations in a Medicaid population.
Latest:
Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related TherapiesExamination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.
Latest:
Estrogens and Lamotrigine: New DevelopmentsPractitioners have known for almost 2 decades that oral contraceptives consistently and substantially reduce the serum concentrations of lamotrigine and may reduce seizure control.
Latest:
Specialty Pharmaceuticals: Manufacturers Must Consider a New Supply ChainFuture strategies to manage specialty drugs are geared toward improving overall health care management of patients rather than relying on supply chain cost reduction strategies. The management of specialty drugs requires strategies that focus on outcomes and value.
Latest:
3 Crucial Considerations for Pharmacists in the Age of ConsumerismAs consumers take on more financial responsibility for their health care, their need grows for more engagement with their pharmacists.
Latest:
Contribution of Phone Follow-up to Improved Adherence to Oral Osteoporosis TreatmentThe authors studied the usefulness of a regular telephone follow-up to improve adherence to oral antiosteoporosis treatments. Their results support such follow-up and the use of this strategy in routine clinical practice.
Latest:
A Look Back and at What Lies Ahead for Specialty Pharmacy in 2019There is no doubt that 2018 was a year of transformation across the health care spectrum, and specialty pharmacy was no exception.
Latest:
A Linezolid Prior Authorization Program: Clinical and Economic OutcomesThis study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.
Latest:
Taking Medication in Diabetes Self-Management: Issues and Recommendations for Reducing BarriersThis paper considers opportunities and barriers relating to medication taking and self-management by people with diabetes and related conditions as discussed during an invitational symposium.
Latest:
How Many Americans with High Cholesterol Could be Eligible for PCSK9 Inhibitors?Specialty drug costs for 13 to 23 million patients in the United States would be $185 to 342 billion.
Latest:
Sponsored Content: Expand Your Pharmacy FootprintWith national brand recognition and expert support, pharmacy franchise owners reach more patients.
Latest:
Impact of Drug Therapy Duration in Patients With Hepatitis CAdherence to drug therapy in hepatitis C increased total costs in year 1 relative to nonadherent patients, then decreased total costs in year 2.
Latest:
Specialty Drugs: Year in Review 2017 Part IIThe second part of a comprehensive review of the specialty pharmaceuticals approved by the FDA in 2017.
Latest:
The Impact of COVID-19 on Medical Science LiaisonsMost notably, COVID-19 has transformed the landscape for medical science liaisons (MSLs) by forcing them to rapidly adapt to the present circumstances.
Latest:
Millennials Not Receiving HIV TestsHalf of millennial-aged men and women said they have never been tested for HIV outside of blood donation.
Latest:
Specialty Pharmacy: Ignoring What It Is and Making It What We WantCurrent definitions attempting to summarize specialty pharmacy fall short.
Latest:
The Deadly "Sins" of Vaccinations: Avoiding Bloodborne DiseasesAs pharmacists administer more vaccines, the risks of needle-stick injury and transmission of a bloodborne disease increase among pharmacists.
Latest:
Comparative Effectiveness of TNF Blockers in Rheumatoid Arthritis PatientsAmong rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.
Latest:
Understanding Vaccine Billing Changes for 2008Recently announced changes in vaccine reimbursement under Medicare have implications for pharmacy billing processes.
Latest:
Overview of the Biosimilar LandscapeBiosimilars, which at the most simplistic level can be thought of as a type of generic option for a biologic, offer an opportunity to help reduce total biologic drug spend.
